These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 8383293)
21. Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein. Heredia L; Lin R; Vigo FS; Kedikian G; Busciglio J; Lorenzo A Neurobiol Dis; 2004 Aug; 16(3):617-29. PubMed ID: 15262274 [TBL] [Abstract][Full Text] [Related]
22. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis. Suzuki T; Araki Y; Yamamoto T; Nakaya T J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045 [TBL] [Abstract][Full Text] [Related]
23. The amyloid peptide and its precursor in Alzheimer's disease. Octave JN Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971 [TBL] [Abstract][Full Text] [Related]
24. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo. Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095 [TBL] [Abstract][Full Text] [Related]
25. Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease. Selkoe DJ Cold Spring Harb Symp Quant Biol; 1996; 61():587-96. PubMed ID: 9246485 [No Abstract] [Full Text] [Related]
26. Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid. Hasegawa T Med Hypotheses; 2007; 69(5):1135-9. PubMed ID: 17499446 [TBL] [Abstract][Full Text] [Related]
27. [Biochemical and molecular study of amyloid protein A4 deposited in senile plaques]. Octave JN; de Sauvage F; Macq AF; Maloteaux JM Acta Neurol Belg; 1989; 89(3-4):276-8. PubMed ID: 2576496 [No Abstract] [Full Text] [Related]
28. [The neuronal cytoplasmic adaptor protein X11L is involved in APP metabolism]. Zhao NQ; Li JG; Yang XR Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):47-51. PubMed ID: 21417016 [No Abstract] [Full Text] [Related]
35. Alzheimer's disease: neurodevelopment converges with neurodegeneration. Bothwell M; Giniger E Cell; 2000 Aug; 102(3):271-3. PubMed ID: 10975517 [No Abstract] [Full Text] [Related]
36. Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type. Hoyer S Ann N Y Acad Sci; 1993 Sep; 695():77-80. PubMed ID: 8239317 [TBL] [Abstract][Full Text] [Related]
37. GAP-43 immunoreactivity is detected in the nerve terminals of patients with amyotrophic lateral sclerosis. Ueki A; Namba Y; Otsuka M; Okuno M; Nishimura M; Oda M; Ikeda K Ann Neurol; 1993 Feb; 33(2):226-7. PubMed ID: 8434888 [No Abstract] [Full Text] [Related]
38. G-protein coupled signal transduction systems in the Alzheimer's disease brain. O'Neill C; Fowler CJ; Winblad B; Cowburn RF Biochem Soc Trans; 1994 Feb; 22(1):167-71. PubMed ID: 8206216 [No Abstract] [Full Text] [Related]
39. Therapeutic approaches targeted at the amyloid proteins in Alzheimer's disease. Caputo CB; Scott CW; Sobel IR; Sygowski LA; Wischik CM; Brunner WF Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():414A-415A. PubMed ID: 1498896 [No Abstract] [Full Text] [Related]
40. Amyloidosis in aging and Alzheimer's disease. Price DL; Walker LC; Martin LJ; Sisodia SS Am J Pathol; 1992 Oct; 141(4):767-72. PubMed ID: 1415474 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]